plasma if free hemoglobin (Hb) levels >0.6g/L, was measured by Harboe 4 spectrophotometric method in any sample (n=91). Shown measurements are the 5 average of 3 technical replicates/patient. Hemolytic samples (red; 1 in the severe 6 SIRS groups and 1 in the non-severe SIRS) were excluded from the study. B. Hb 7 levels are shown in any experimental group used in NGS and miRNA Q-PCR array, 8 after the exclusion of outliers. Importantly, average Hb did not differ significantly 9 across groups, suggesting that RBC lysis is equally represented across the 10 experimental groups prior to the NGS analysis. RBCs may be responsible for miRNA 11 presence in the blood. Balancing the levels of miRNAs across experimental groups 12 may also positively affect normalization. In fact in our analysis, the internal 13 normalizer miR-486-5p is one of the most abundant miRNA circulating in blood and 14 is mostly derived from RBC. Cp of miR-23a/miR-451a assays in two independent, technical repeat experiments -4
shown respectively in the black and in the red lines for each individual sample (x-5 axis, n=89). If the miR-23a/miR-451a ratio cut off >7 is reached samples are 6 excluded from any further analysis. In agreement with our previous 7 spectrophotometric analysis (Supplementary Figure 1) , the qPCR platform confirmed 8 similar levels of hemolysis across the groups and only 1 patient sample in the severe 9 sepsis group was deemed to be excluded from further analysis. 
SIRS and Sepsis after correction for multiple confounding variables. 3
Hierarchical binary logistic regression models of the Sepsis/SIRS predictive value 4
were generated based on each of the top 6 CIR-miRNAs (A), and their combination 5 (B), after controlling for a number of confounding variables. The confounding 6 variables (SOFA score, age, sex, patient survival outcome, and time of sample 7 collection) were introduced at the first level (block 1) of the regression models. having Sepsis/SIRS. This suggests that the predictive values of the top 6 CIR-25 miRNA is preserved after controlling for a number of confounding variables. In the 1 case of miR-191, even if the total significance of the model is p=0.056, the second 2 step significantly improved the model prediction (p=0.008). It should be noted that 3 since in our study SOFA and age were rigorously matched the interval of these 4 variables is consequently limited (see Table 1 ). As patients were coming from the 5 same ICU type, this was not deemed to be a confounding variable in our study. 6 (n=21 and n=23 for sepsis and SIRS respectively, except n=20 in sepsis for miR-30a 7 and the combined score) 
Sample handling and normalization of hemolysis 8
Study blood samples were collected in Na-citrate tubes from patients within 6 hours 9 of ICU admission and centrifuged. Plasma was stored at -80°C until the day of 10 analysis, thawed on ice and kept at 4°C until the RNA extraction. Plasma was stored 11 at -80°C until the day of analysis, thawed on ice and kept at 4°C until the RNA 12 extraction. Red blood cell (RBC) lysis during sample handling has the potential to 13 bias microRNA content in plasma [1] [2] [3] [4] . 
1
After exclusion of hemolysis specimens, plasma pools were formed by combining 2 equal volumes of patients' plasma in the groups of . Briefly, each sample was denatured and processed according to 5 manufacturer's instructions to extract RNA with Acid-Phenol:CHCl 3 ; the recovered 6 aqueous phase was mixed with ethanol (molecular biology grade; SIGMA; 1:1.25) 7
and loaded onto replicate columns to bind RNA. After multiple column washes, RNA 8 was eluted in 95°C DEPC-treated H 2 0 (Life Technologies) from replicate columns, 9
pooled and quantified using a Nanodrop spectrophotometer. Typically we recovered 10 679±165 pg RNA/μl of plasma (mean±SD). On the same day, an average RNA input 11 of 849±206 ng (mean±SD) was created for technical duplicates of NGS and stored at 12 -80°C. Before cDNA library preparation for NGS, RNA preparations were validated 13 for the presence of miRNA using a Taqman miRNA assay (Life Technologies) for 14 human miR-16. NGS cDNA libraries were prepared and validated from plasma RNA 15 by ARK Genomics (University of Edinburgh, UK), following manufacturer 16 instructions, with specific barcodes for each cDNA library (Illumina TruSeq Small 17 RNA sample protocol). Briefly, samples were ligated with an adapter (3' end) and a 18 primer (5' end) before being reversely transcribed. The cDNA obtained was used as 19 a template for PCR to add sample specific barcodes and extend adapters. 20
Thereafter, samples were purified by electrophoresis (6% polyacrylamide gels) and 21 bands corresponding to ~22 nucleotides in the original sample were size-selected 22 System (Roche) in 384-well plates. The amplification curves were analyzed using the 7 Roche LC software, both for determination of Cq (2nd derivative method) and for 8 melting curve analysis. Amplification efficiency was calculated using a linear 9 regression method. All assays were inspected for distinct melting curves and the Tm 10 was confirmed to be within known specifications for the assay. Assays returning 3 11
Cq less than the negative control and Cq<37 were accepted and sample runs not 12 matching these criteria were omitted from further analysis (e.g., miR-92b-3p). 13
The stability values of candidate normalizers were assessed using the 'NormFinder' 14 software 12 . Any qPCR data was normalized to the average Cp of internal normalizers 15 detected in all samples (delta Cp; dCp=normalizer Cp-assay Cp). All miRNA 16 analyses were conducted blind to the clinical data. 17
18

Cytokine and inflammatory biomarker measurements 19
Cytokine levels (IL-6, IL-8, IL-1β) were measured on a Luminex LX200 using 20 
Statistical analyses 4
Unless specified, datasets were analyzed and plotted (including receiver operator 5 curves, ROC) using the GraphPad Prism 6 and/or IBM SPSS Statistics 22 software. 6
The D'Agostino and Pearson omnibus and/or Shapiro-Wilk tests were used to test 7 normal data distribution. If not normally distributed, medians with interquartile ranges 8 (IQR, rather than means and standard deviation, SD) are shown and Mann-Whitney 9 U Test (rather than t-) tests were used to calculate p-values in 2-group comparisons. 10 Significances across more than 2 groups were assessed by ANOVA (Kruskal-Wallis 11 test). For the qPCR miRNA array dataset, a multiple testing correction was used to 12 adjust ordinary p-values in order to control for the number of false positives 13 
